US Patent Issued to FRIEDRICH-SCHILLER-UNIVERSITAET JENA on Nov. 18 for "Peptide for use in the reduction of side effects in the form of immunostimulatory reactions/effects" (German Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,262, issued on Nov. 18, was assigned to FRIEDRICH-SCHILLER-UNIVERSITAET JENA (Jena, Germany).

"Peptide for use in the reduction of side effects in the form of immunostimulatory reactions/effects" was invented by Tobias Poehlmann (Zwickau, Germany), Rolf Guenther (Hamburg, Germany), Michael Reuter (Jena, Germany) and Mirko Ludwig (Jena, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "What is described is a peptide for use in the reduction of side-effects in form of immunostimulatory reactions/effects which occur with gene therapy, wherein the peptide is coupled to a nucleic acid molecule used in gene therapy. Furthermore, such a peptide is des...